Interleukin-11 (IL-11) accumulates in aging ovaries and drives fibroblast activation, increasing tissue stiffness and impairing reproductive function. Blocking IL-11 restores ovarian compliance and delays reproductive senescence across multiple species.
Key Points
- IL-11 elevation in aging ovaries activates fibroblasts to produce excessive extracellular matrix
- Ovarian stiffness impairs function; IL-11 inhibition reverses this mechanical constraint
- Findings replicate across mice, rats, and humans with therapeutic potential
Longevity Analysis
Reproductive aging represents a systemic event driven by tissue stiffness and inflammatory signaling, not inevitable cellular decline. This work identifies a specific mechanical bottleneck—excessive matrix deposition—that can be pharmacologically reversed, suggesting reproductive capacity is preserved longer than previously thought when inflammatory drivers are removed. The approach demonstrates that aging phenotypes rooted in structural changes may respond to targeted interventions that restore tissue compliance, with implications extending beyond reproduction to other organs where age-related fibrosis limits function.
Original published by Nature Aging, by Meng Wu.